ID   USZ20-EMC1
AC   CVCL_C6MX
SY   UniversitatsSpital Zurich 2020-Extraskeletal Myxoid Chondrosarcoma 1
DR   Wikidata; Q116050751
RX   PubMed=36316541;
CC   Characteristics: Maintained as a sarco-sphere (PubMed=36316541).
CC   Doubling time: 5.09 days (PubMed=36316541).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:7982; NR4A3; Name(s)=EWSR1-NR4A3; Note=EWSR1 exon 13 fused to NR4A3 exon 2 (PubMed=36316541).
CC   Omics: DNA methylation analysis.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
ST   Source(s): PubMed=36316541
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 13,15
ST   Penta E: 5,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C27502; Extraskeletal myxoid chondrosarcoma
DI   ORDO; Orphanet_209916; Extraskeletal myxoid chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=36316541; DOI=10.1007/s13577-022-00818-x; PMCID=PMC9813045;
RA   Bangerter J.L., Harnisch K.J., Chen Y.-J., Hagedorn C., Planas-Paz L.,
RA   Pauli C.;
RT   "Establishment, characterization and functional testing of two novel
RT   ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models.";
RL   Hum. Cell 36:446-455(2023).
//